The loss of companionship is perhaps the initial beginning of relationship changes. The partner, now assuming a caregiver ...

Dr. Joanne Pike, CEO of the Alzheimer's Association, talks about the challenges and hopes when it comes to this debilitating ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Alzheimer’s is a disease that knows no stranger. “It’s actually the seventh leading cause of death in the United States,” ...

The European Union's drugs regulator on Thursday recommended approval of Eisai and Biogen's Leqembi for some patients with ...

An analysis of cerebrospinal fluid has uncovered several proteins likely involved in the development and progression of ...

A new study finds that brain shrinkage in Alzheimer’s disease varies greatly among individuals, with distinct patterns rather than a uniform progression. These findings may pave the way for ...

That Thursday, for the first time, the European Medicines Agency (EMA) approved a drug that targets the cause — not just the ...

The last of three walks to end Alzheimer’s is wrapping up this weekend. November is Alzheimer's Awareness Month across the ...

New recommendations to help healthcare providers explain amyloid therapies to Alzheimer’s patients and their caregivers involve sharing the benefits and risks of the medications.

A study reveals the link between specific nutrients and a reduced risk of Alzheimer's. Find out which foods contain these ...

Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved ...